|
|
Press
|
|
 |
|
|
Novel Laser Coding Technology for Pharmaceutical Glass Containers
Glass syringes can now be individually coded / Safe process free of micro-cracks / Reliable Track & Trace
A completely new innovative laser-coding system enables glass containers for parenteral use to be clearly coded at the glass syringe manufacturer and tracked from production to end customer. This innovation can help pharmaceutical companies to
develop a reliable Track & Trace system and further reduce the risk of mix-up of syringes and batches. At the same time, this laser-coding technology is an effective means to counter drug counterfeiters. More
|
|
|
|
SCHOTT to strengthen its presence in South America
Acquisition of the pharmaceutical packaging business from Medical Glass and DIESCA in Argentina
Mainz (Germany) / Buenos Aires (Argentina), July 8, 2009 - SCHOTT Pharmaceutical Packaging has strengthened its presence in South America by taking over the business from Medical Glass S.A., the market leader in Argentina, as well as DIESCA S.A. Effective immediately, both companies will begin trading under the new name SCHOTT Envases Argentina S.A.
More
|
|
|
|
SCHOTT Developing Syringe Production in United States
Announces Expanded Product Line
SCHOTT Developing Syringe Production in United States
Announces Expanded Product Line, Production Capacity in the Pennsylvania Plant at INTERPHEX
March 17, 2009 (at INTERPHEX 2009 in New York) — SCHOTT’s Pharmaceutical Packaging business announced an expansion of both its product line and production capacity in the United States today. The company will add the full line of SCHOTT ready-to-fill syringe products to its portfolio of vials and cartridges manufactured at its existing Pharmaceutical Packaging facility in Lebanon, Penn.
More
|
|
|
|
New “Sterile Standard Syringe Set” for sampling purposes
St. Gallen (Switzerland), January 15, 2009 - SCHOTT forma vitrum offers a complete syringe package with all components and full documentation ready-to-deliver from stock. More
|
|
|
2008 | |
|
|
SCHOTT opens new plant in Suzhou, China
SCHOTT extends activities in High-End Pharmaceutical Packaging to Chinese market. More
|
|
|
|
Tailor-made product solutions for the highest requirements
New production facility for „TopLine” vials in Indonesia
Lippo Cikarang-Bekasi/Indonesia – In order to meet the demand of the high end market in Asia, SCHOTT forma vitrum has opened a new production facility for “TopLine” vials in its Indonesian manufacturing plant. More
|
|
|
|
Hydrophobic Coatings for Sensitive Biotechnology Preparations
SCHOTT forma vitrum introduces innovative product for use with lyophilized substances
St. Gallen, Switzerland, April 24, 2008 – SCHOTT has developed a completely unique coating for use with pharmaceutical applications. The surfaces of the vials that contain these hydrophobic layers are so homogeneous, for instance, that lyophilized (freeze-dried) substances are unable to adhere to the interior walls of these vials. This not only improves the visual appearance, but also makes it easier for water to dissolve these substances. More
|
|
|
|
SCHOTT Forms Pharmaceutical Joint Venture in India
SCHOTT AG and KAISHA Manufacturers Private Ltd., an Indian company, announce the formation of a joint venture, SCHOTT KAISHA Private Ltd. The new joint venture will manufacture primary pharmaceutical packaging made of glass for the Indian market. The joint enterprise will have operations in Mumbai and Daman. More
|
|
|
|
Road clear for “Fiolax” in China
SCHOTT-Rohrglas becomes the world’s first certified importer of specialized glass tubing for pharmaceutical packaging to China
Mainz, Germany / Suzhou, China, April 16, 2008 – SCHOTT-Rohrglas, with its SCHOTT “Fiolax” glass for pharmaceutical use, has now become the world’s first importer to be certified for the Chinese market by the State Food and Drug Administration of the People’s Republic of China, SFDA. More
|
|
|
2007 | |
|
|
SCHOTT Secures Research Funding to Improve Glass Packaging for Vaccines and Drugs
Lebanon, Pa. / USA City, December 19, 2007 – The U.S. Department of Defense, along with Congressman Tim Holden (D -PA), today announced that SCHOTT North America has been awarded an appropriation of 800,000 US$ in federal funding, which Congressman Holden inserted into the Defense Appropriations Bill. The funding will allow SCHOTT to conduct research into the interaction between biotherapeutic drugs and glass packaging. Currently, such interactions can lead to drug loss due to adsorption, aggregation and precipitation, which diminishes the effectiveness of these drugs. More
|
|
|
|
SCHOTT to Open Pharmaceutical Packaging Production Facility in Russia
SCHOTT seeks to strengthen its position in Russia / Production to begin in 2009
SCHOTT Pharmaceutical Packaging, a leading worldwide supplier of parenteral packaging to the pharmaceutical industry, has decided to build the company’s first production facility located in the Russian Federation. The new plant is expected to become operational in 2009. The facility will be based in Bor, a city located near the fourth largest city in Russia, Nizhny Novgorod.
“This move is of great strategic importance to our pharma business, it will strengthen the company’s leading position and allow for pharmaceutical customers based in the Commonwealth of Independent States to be served more effectively,” says Prof. Dr.-Ing. Udo Ungeheuer, Chairman of the Board of Management of SCHOTT AG.
More
|
|
| Top |
|
Contact
Pharmaceutical Packaging
SCHOTT forma vitrum ag
St. Josefen-Straße 20 P. O. Box 9001 St. Gallen Switzerland
 | +41 (0)712741600 |
 | +41 (0)712741616 |
E-mail
More contacts
|
